<DOC>
	<DOCNO>NCT02023372</DOCNO>
	<brief_summary>The purpose study determine whether NuCel effective promote spinal fusion degenerative disease lumbar spine .</brief_summary>
	<brief_title>Efficacy Study NuCelÂ® Patients Undergoing Fusion Lumbar Spine</brief_title>
	<detailed_description>The study prospective , single center clinical trial establish efficacy NuCel , minimally manipulate allograft tissue , use lumbar interbody intertransverse fusion procedure . Subjects undergo standard interbody fusion surgery per sign informed consent NuCel autograft bone . Patients evaluate postoperatively 6 week , 3 month , 6 month , 1 year , 2 year ( require ) .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<mesh_term>Spondylosis</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<criteria>Must diagnose degenerative disease lumbar spine Back pain due injury Back pain cause infection , cancer , lesion ( growth ) bone disease osteoporosis Any terminal ( recover disease ) autoimmune disease include limited HIV infection , rheumatoid arthritis Any medical condition might affect normal heal Less 21 year age More three level fusion need Recent history ( within past 6 month ) chemical alcohol dependence Morbid obesity ( Body Mass Index 40 ) Currently prisoner Currently experience major mental illness Pregnancy time enrollment Previously diagnose diseases bone osteoporosis , osteopenia osteomalacia ( soften bone ) . Patients risk factor osteoporosis may DEXA scan perform prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>NuCel</keyword>
	<keyword>Lumbar Spine</keyword>
	<keyword>Degenerative Disease</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Fusion</keyword>
</DOC>